Veeda Clinical Research
 
Japanese Francais
 
Home | Veeda Oncology | Veeda Biometrics |  Sitemap |  Search :  
 
 
Quick Links
 
 
Phase 1 Clinical Trials, Uk and India Clinical Research, CRO
Home » About Us » Key People » Management
Phase 1 Clinical Trials india,UK,Clinical REsearch
Indian CRO,Contract Research Organisations, India,Phase 1 clinical trials
Penny Thorne
Dr. Malcolm John Mills – Chief Scientific Officer
 

Dr Mills, started his CRO career with Drug Development Scotland in 1987 where he had responsibility for analytical method development and validation and helped to establish the unit’s GLP compliance programme. After completing his doctorate in Bio Analysis in 1996, he headed a project in the Autism Research Unit at the University of Sunderland. In 1997 he returned to the regulated pharmaceutical research industry and after spells at both Quintiles and GlaxoWellcome he joined a leading Phase 1 CRO, DDS Medicines Research as Head of Analytical Services.

Following a MBO in 2005, Dr Mills was appointed to the role of Director of Support Services where he was responsible for QA, laboratory services, data management, vendor selection, Pharmacy and IT. On his subsequent promotion to Director of Operations, Dr Mills was additionally responsible for clinical operations and project management and in this position was a member of the Senior Executive and Board of Directors.

In 2008, Dr Mills joined Veeda Clinical Research as Chief Scientific Officer, where he is responsible for advising the company on a wide range of analytical, study management and regulatory issues.

He has several publications on the subjects of organic and analytical chemistry resulting from his academic research and has presented at major academic and industry oriented seminars worldwide over the course of his career which has spanned over 20 years.

 
To know more about Veeda services or if you have any query please click here to contact us
 
Back
 
Phase 1 India,Clinical Research,Bioavailability,phase I unit
Bioequivalence,ECG Studies,QTC studies,Phase I/IIa studies
 
 
Disclaimer | ©2005-2010 Veeda Clinical Research Limited
 
Veeda Clinical Research and Veeda Oncology are registered trademarks of Veeda Clinical Research, Inc.
   
 
Ver. 1.76 (Last Updated - 30 June 2010)